Silent emergence of Mycoplasma pneumonia from 2022 to 2024

Le résumé fourni par la source

Objectives: Community-acquired pneumonia has been associated with increased morbidity and death, and it poses a serious threat to public health worldwide. Coughing and sneezing can spread aerosols of the Mycoplasma pneumoniae bacterium; infections are normally self-limiting and mild, but they may turn into serious or even life-threatening diseases in some individuals. Increased risk of M. pneumoniae in the post-COVID-19 situation. Materials and Methods: Retrospective research on patients infected with M. pneumoniae, including polymerase chain reaction (PCR) analysis from January 2022 to December 2024 at Mani Microbiological Laboratory Pvt Ltd. A total of 19242 cases were requested for respiratory tract illness. Fast track diagnosis - respiratory pathogen identification with the TaqMan probe test. Amplification was carried out using Rotor-Gene Q 5 plex and MIC PCR. The results analyzed were documented. Results: Over 790/19242 cases tested positive for M. pneumoniae, of which 436 individuals were male, and 354 individuals were female. In December, 201 (24%) individuals were infected with M. pneumoniae; 122 individuals were infected in the notifiable age group (2–4) as reported by the Center for Disease Control and Prevention. pre-COVID-19 and during the COVID-19 pandemic situation from 2018–2021, including (62/1156) the M. pneumoniae-infected individuals. Conclusion: In this study, an elevated number of young children were infected with M. pneumonia, leading to a high risk; children between the ages of 2-4 were infected in high numbers and were considered to be a notable one. The salient emergence of M. pneumoniae in the Southern parts of India was recorded in this study.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.